Thirty-one percent of adult Americans are not simply overweight, they are clinically diagnosed as obese. This translates into 500 million people. Obesity has become one of the most serious threats to Americans health and well-being. Figures show that obesity rates in the United states have steadily risen over the last 25 years and have reached epidemic proportions.
It would take an army of accountants to forecast the medical and direct costs associated with obesity, but it is well documented that obesity is directly associated serious health issues such as heart attack, stroke, high blood pressure, and diabetes; making obesity one of the major factors that cause preventable death in U.S.
On the new product front, there is great news. Vivus Pharmaceuticals have recently announced a new weight loss pill, designated for considerable weight loss for obese patients. This groundbreaking medication is named Qsymia, a weight loss pill that was recently approved for prescription by the Food and drug administration.
The significance is that this medication was approved by the FDA this year; while the FDA has been reluctant to approve any weight loss medications in the last ten years. The pills performance has been noteworthy. Qsymia is a combination drug, consisting of two drugs, which are known to have varying degree of effectiveness with obese patients. Together is seems to be quite the combination.
This weight loss drug among other things, is approved under strenuous clinical study. Patients were monitored while on Qsymia for 12 consecutive months. In one study, patients lost an average of 6.7 per cent of body weight, while in the other, patients lost an average of 8.9 per cent. Patients on the highest dosages reported significant body weight loss as high as 22 pounds.
Researchers have determined that Qsymia is so effective because it targets two completely separate areas that cause overeating. The drugs that comprise the weight loss pill are Topiramate and Phentermine. The former is an anti-consultant, which makes the patient feel more satisfied after a meal. The latter is an appetite suppressant.
It is a scientific fact that significant weight loss lowers risk for catastrophic health concerns. Patients in the FDA studies report positive results for blood pressure, diabetic therapy and even lessening of symptoms associated with sleep apnea by the end of the trial period.
Qsymia has been approved for use, but not unrestricted use. Current guidelines suggest that the drug only be prescribed for patient with a BMI (Body mass index) greater than 30. In other words, the drug is for those clinically revealed as obese. In addition, Physicians and clinics that administer the drug are advised to closely monitor the patients. Side effects include congenital disorder in infants, if taken by women who are pregnant.
Qsymia is proving to be one of the best tools in the struggle to overcome obesity and get America healthy again. The foremost physicians and weight loss clinics have responded by offering Qsymia as an option for their patients. Equilibrium weight loss and longevity clinics offer Qsymia as part of a comprehensive line of weight loss programs.
It would take an army of accountants to forecast the medical and direct costs associated with obesity, but it is well documented that obesity is directly associated serious health issues such as heart attack, stroke, high blood pressure, and diabetes; making obesity one of the major factors that cause preventable death in U.S.
On the new product front, there is great news. Vivus Pharmaceuticals have recently announced a new weight loss pill, designated for considerable weight loss for obese patients. This groundbreaking medication is named Qsymia, a weight loss pill that was recently approved for prescription by the Food and drug administration.
The significance is that this medication was approved by the FDA this year; while the FDA has been reluctant to approve any weight loss medications in the last ten years. The pills performance has been noteworthy. Qsymia is a combination drug, consisting of two drugs, which are known to have varying degree of effectiveness with obese patients. Together is seems to be quite the combination.
This weight loss drug among other things, is approved under strenuous clinical study. Patients were monitored while on Qsymia for 12 consecutive months. In one study, patients lost an average of 6.7 per cent of body weight, while in the other, patients lost an average of 8.9 per cent. Patients on the highest dosages reported significant body weight loss as high as 22 pounds.
Researchers have determined that Qsymia is so effective because it targets two completely separate areas that cause overeating. The drugs that comprise the weight loss pill are Topiramate and Phentermine. The former is an anti-consultant, which makes the patient feel more satisfied after a meal. The latter is an appetite suppressant.
It is a scientific fact that significant weight loss lowers risk for catastrophic health concerns. Patients in the FDA studies report positive results for blood pressure, diabetic therapy and even lessening of symptoms associated with sleep apnea by the end of the trial period.
Qsymia has been approved for use, but not unrestricted use. Current guidelines suggest that the drug only be prescribed for patient with a BMI (Body mass index) greater than 30. In other words, the drug is for those clinically revealed as obese. In addition, Physicians and clinics that administer the drug are advised to closely monitor the patients. Side effects include congenital disorder in infants, if taken by women who are pregnant.
Qsymia is proving to be one of the best tools in the struggle to overcome obesity and get America healthy again. The foremost physicians and weight loss clinics have responded by offering Qsymia as an option for their patients. Equilibrium weight loss and longevity clinics offer Qsymia as part of a comprehensive line of weight loss programs.
About the Author:
Are you looking to find out if Qsymia Capsules are available around you? We all will have to get a prescription to get the Qsymia diet pills
No comments :
Post a Comment